In group 0, several immune checkpoint and pro-inflammatory genes, including PDCD1LG2 (PD-L2), CD274 (PD-L1), HLA-A, CXCL10, and CD163, displayed relatively high expression, suggesting a more inflamed tumor microenvironment. This evidence concerns the gene PDCD1LG2 and neoplasm.